Market revenue in 2023 | USD 277.7 million |
Market revenue in 2030 | USD 661.6 million |
Growth rate | 13.2% (CAGR from 2023 to 2030) |
Largest segment | Synthetic/ blend of natural & synthetic |
Fastest growing segment | Natural |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Natural, Synthetic/ Blend of Natural & Synthetic |
Key market players worldwide | Fairhaven Health, Vitabiotics, Mankind Pharma, extreme V, Coast Science, Orthomol, Exeltis, bioNova, Innovamed, PlusPlus LifeSciences, Eu Natural |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to fertility supplements market will help companies and investors design strategic landscapes.
Synthetic/ blend of natural & synthetic was the largest segment with a revenue share of 88.44% in 2023. Horizon Databook has segmented the China fertility supplements market based on natural, synthetic/ blend of natural & synthetic covering the revenue growth of each sub-segment from 2018 to 2030.
The trend of women choosing to delay having children is growing, which increases the chances of reduced fertility or complications as they age. This is likely to drive the demand for fertility supplements. Compared to Singapore, South Korea, Taiwan, Hong Kong, and Taiwan, China already has one of the lowest fertility rates in the world.
Beijing has been implementing various policies, such as financial incentives and improved childcare facilities, to address the declining birth rate resulting from the country's first population decline in six decades and the acceleration of its aging demographic.
In addition, the Family Planning Association of Hong Kong reported a significant increase in the number of childless women in the region—from the number recorded five years ago to 43.2% last year. According to the National Institutes of Health (NIH), Taiwan ranked among the countries with the lowest global fertility rates as of December 2020, an issue linked to the country's aging population.
Horizon Databook provides a detailed overview of country-level data and insights on the China fertility supplements market , including forecasts for subscribers. This country databook contains high-level insights into China fertility supplements market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account